Recovery of Adrenal Function after Long-Term Glucocorticoid Therapy for Giant Cell Arteritis: A Cohort Study
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Giant cell arteritis (GCA) is a chronic systemic vasculitis of large and medium-sized arteries, for which long-term glucocorticoid (GC) treatment is needed. During GC withdrawal patients can suffer adrenal insufficiency. We sought to determine the time until recovery of adrenal function after long-term GC therapy, and to assess the prevalence and predictors for secondary adrenal insufficiency. SUBJECTS AND DESIGN: 150 patients meeting the ACR criteria for GCA between 1984 and 2012 were analyzed. All received the same GC treatment protocol. The low-dose ACTH stimulation test was repeated annually until adrenal recovery. Biographical, clinical and laboratory data were collected prospectively and compared. RESULTS: At the first ACTH test, 74 (49%) patients were non-responders: of these, the mean time until recovery of adrenal function was 14 months (max: 51 months). A normal test response occurred within 36 months in 85% of patients. However, adrenal function never recovered in 5% of patients. GC of >15 mg/day at 6 months, GC of >9.5 mg/day at 12 months, treatment duration of >19 months, a cumulative GC dose of >8.5 g, and a basal cortisol concentration of <386 nmol/L were all statistically associated with a negative response in the first ACTH test (p <0.05). CONCLUSION: Adrenal insufficiency in patients with GCA, treated long-term with GC, was frequent but transitory. Thus, physicians' vigilance should be increased and an ACTH test should be performed when GC causes the above associated statistical factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prior studies have shown that adrenal insufficiency may last even up to 2-4 years after glucocorticoid cessation, owing to slow recovery of adrenal cortisol production (40, 47, 122-124).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [47]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Studies assessing recovery of HPA axis function through measurement of morning cortisol or low-dose 1 µg ACTH (1-24)-test were not formally included in the systematic review (see “Clinical questions, eligibility criteria, and definition of endpoints’), but reported recovery incidence rates of 17% to 100% within a range of 4 days to 3 years (43-50).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [47]
In the citing paper
“Data on recovery of the HPA axis after exposure to a suppressive dose of glucocorticoids are limited and often in studies that have recruited small numbers of patients (ranging from n = 1 to 49) (10,(26)(27)(28)(29)(30)(31)(32)(33)(34)(35).”
From The short synacthen (corticotropin) test can be used to predict recovery of hypothalamo-pituitary-adrenal axis function (2018) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DICKSTEIN, G., SHECHNER, C., NICHOLSON, W. E., ROSNER, I., SHEN-ORR, Z., ADAWI, F., & LAHAV, M. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-4-773 · Cited by 457
Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis
Kazlauskaite, R., Evans, A. T., Villabona, C. V., Abdu, T. A. M., Ambrosi, B., Atkinson, A. B., Choi, C. H., Clayton, R. N., Courtney, C. H., Gonc, E. N., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0710 · Cited by 385 · cited 2×
“has demonstrated that low-dose test was superior to the standard test [7,17].”
BackgroundResultDiagnosis of Adrenal Insufficiency
Dorin, R. I., Qualls, C. R., & Crapo, L. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-3-200308050-00009 · Cited by 374
Predisposing Factors for Adrenal Insufficiency
Bornstein, S. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804635 · Cited by 356 · cited 1×
“Although chronic inflammation is known to inhibit the hypothalamic-pituitary-adrenal (HPA) axis [3], glucocorticoid therapy remains the first cause of HPA dysfunction [4].”
BackgroundWright, A., & Coombes, A. E. R. (1948) · The Lancet · doi:10.1016/s0140-6736(48)91204-5 · Cited by 347
Treatment of amosbic dysentery.
Wright, A., & Coombes, A. E. R. (1948) · PubMed · Cited by 345
A rapid test of adrenocortical function
Wood, J. B., James, V. H. T., Frankland, A. W., & Landon, J. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91526-6 · Cited by 312 · cited 1×
“Our study confirmed that total dose and duration of GC were predictive factors [8,11,13].”
BackgroundHUNDER, G. G., SHEPS, S. G., ALLEN, G. L., & JOYCE, J. W. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-5-613 · Cited by 299
Giant cell arteritis: A review of classification, pathophysiology, geoepidemiology and treatment
Borchers, A. T., & Gershwin, M. E. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.01.003 · Cited by 256
BIOLOGICAL ASPECTS OF SOCIAL PROBLEMS.
PASSMORE, R. (1964) · PubMed · Cited by 202
Research works printed but not linked: 1
- F Luca, 2013, [Secondary adrenal insufficiency due to exogenous glucocorticoid therapy], Rev Med Interne, 34, 324
Cited by
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
Hellmich, B., Agueda, A., Monti, S., Buttgereit, F., de Boysson, H., Brouwer, E., Cassie, R., Cid, M. C., Dasgupta, B., Dejaco, C., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215672 · Cited by 1,200
Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis
Broersen, L. H. A., Pereira, A. M., Jørgensen, J. O. L., & Dekkers, O. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1218 · Cited by 456
Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis
Paragliola, R. M., Papi, G., Pontecorvi, A., & Corsello, S. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102201 · Cited by 181
“It is not clear whether or not the dose and the duration of GCs therapy increase the risk of developing adrenal insufficiency: some authors found no relationship between either the dose or duration of therapy and adrenal insufficiency [13], while others found that both cumulative doses and treatment durations are asso…”
BackgroundSystemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review
Joseph, R. M., Hunter, A. L., Ray, D. W., & Dixon, W. G. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.03.001 · Cited by 179
“Excluding the studies retesting a single patient, the percentage of patients with AI persisting at the end of follow-up ranged from 75% (after 10 weeks of cessation) [48] to 15% (after 3 years of cessation) [13,73].”
InfluentialBeuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae250 · Cited by 172
Metadata
- Authors
- Jamilloux, Y., Liozon, E., Pugnet, G., Nadalon, S., Heang Ly, K., Dumonteil, S., Gondran, G., Fauchais, A.-L., & Vidal, E.
- Affiliations
- Centre Hospitalier Universitaire de Limoges (FR)
- Centre Hospitalier Universitaire de Toulouse (FR)
- Corresponding author
- Jamilloux, Yvan
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-24
- Volume
- 8
- Issue
- 7
- Pages
- e68713
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3722149
- OpenAlex
- W1972810095
- Cited by
- 59
- References
- 23
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 8 · 2020: 4 · 2019: 3 · 2018: 9 · 2017: 3 · 2016: 4 · 2015: 6 · 2014: 3 · 2013: 1
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-12-20)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- giant cell arteritis, glucocorticoid therapy, secondary adrenal insufficiency, adrenal function recovery, ACTH stimulation test, glucocorticoid dose, treatment duration, basal cortisol
- MeSH terms
- Adrenal Insufficiency, Adrenocorticotropic Hormone, Aged, Aged, 80 and over, Female, Glucocorticoids, Humans, Male, Giant Cell Arteritis, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recovery of Adrenal Function after Long-Term Glucocorticoid Therapy for Giant Cell Arteritis: A Cohort Study. https://app.cochat.ai/papers/10.1371/journal.pone.0068713
- The paper
- Jamilloux, Y., Liozon, E., Pugnet, G., Nadalon, S., Heang Ly, K., Dumonteil, S., Gondran, G., Fauchais, A.-L., & Vidal, E. (2013). Recovery of Adrenal Function after Long-Term Glucocorticoid Therapy for Giant Cell Arteritis: A Cohort Study. PLoS ONE. https://doi.org/10.1371/journal.pone.0068713
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
